Ras inhibitors with a tricyclic core
TW202639558APending Publication Date: 2026-10-01ASTRAZENECA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115103751
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-31
- Filing Date
- 2026-01-30
- Publication Date
- 2026-10-01
Abstract
The present specification relates to compounds, and pharmaceutically acceptable salts thereof, that inhibit the growth of cancers that express G13D mutant Ras proteins. The molecules of the specification are thus indicated for use in the treatment of Ras G13D mutant cancers and for use in methods for the treatment of Ras G13D mutant cancers.
Need to check novelty before this filing date? Find Prior Art